NCT04989803
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04989803
Title Study Evaluating the Safety and Efficacy of KITE-363 in Participants With Relapsed and/or Refractory B-cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kite, A Gilead Company
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | GBR | DEU | AUS

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center RECRUITING Gilbert Arizona 85234 United States Details
Stanford Cancer Institute RECRUITING Stanford California 94305 United States Details
Northside Hospital RECRUITING Atlanta Georgia 30342 United States Details
University of MD, Greenebaum Comprehensive Cancer Center RECRUITING Baltimore Maryland 21201 United States Details
Hackensack University Medical Center RECRUITING Hackensack New Jersey 07601 United States Details
Columbia University Irving Medical Center RECRUITING New York New York 10032 United States Details
University of Rochester Medical Center RECRUITING Rochester New York 14642 United States Details
The Ohio State University Wexner Medical Center - James Cancer Hospital RECRUITING Columbus Ohio 43210 United States Details
The University of Texas, MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Virginia Oncology Associates RECRUITING Norfolk Virginia 23502 United States Details
Royal North Shore Hospital RECRUITING St Leonards New South Wales 2065 Australia Details
Universitatsklinikum Wurzburg RECRUITING Würzburg 97080 Germany Details
Academisch Medisch Centrum RECRUITING Amsterdam 1105 AZ Netherlands Details
King's College Hospital RECRUITING London SE5 9RS United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field